The pharmaceutical industry is increasingly adopting the use of AI in its search for new drugs. But how will the industry respond to the example of the auto industry, and how should the use of AI interact with the traditional scientific process? This article is taken from European Biopharmaceutical Review January 2022, pages 56-57. © Samedan Ltd